The presence of ETS-1 in tissues derived from the neural crest, as melanocytes, might suggest the association of ETS-1 downregulation with the loss of the neural crest-associated phenotype during melanoma progression; nevertheless, our data speak in favor of its role in tumorigenesis. The gene discussed is ETS1; the disease is melanoma.